The researchers found that excess glucose, alcohol or acetate activated a mitochondrial reactive oxygen species signaling pathway, which engaged the integrated stress response and the transcription factor CEBPB. This signaling increased ACSS1, a protein involved in converting acetate into acetyl-CoA. Once accumulated, ACSS1 raised acetyl-CoA production from supplied acetate or from acetate generated internally from glucose or ethanol.

The metabolic rewiring promoted excessive protein acetylation and specifically inactivated malate enzyme 2 (ME2) through acetylation at lysine 94. ME2 inactivation disturbed the malate-aspartate shuttle and, according to the study, created a self-perpetuating cycle of redox imbalance and oxidative stress. That cycle intensified mitochondrial dysfunction and impaired the osteogenic capacity of the affected cells.

The mechanism therefore connected several elements of the stress response: acetate metabolism, acetyl-CoA abundance, protein acetylation, mitochondrial communication and the differentiation of cells that form bone. ACSS1 was identified as a key stress responder that mediated this mitonuclear communication in bone marrow skeletal stem cells. Genetic deletion of Acss1 in male mouse models of type 2 diabetes and chronic alcohol consumption restored mitochondrial resilience, osteogenic capacity and bone formation.

The researchers also used an adeno-associated virus to deliver a non-acetylatable ME2 mutant to osteoprogenitor cells; this approach produced protective effects in the models tested. Deletion of Acss1 protected against osteoporosis or osteonecrosis, while delivery of the ME2 mutant similarly counteracted the bone-forming defects associated with the experimental metabolic stresses. Because the reported experiments were conducted in mice and bone-forming cells, the results establish a mechanism in those systems rather than a clinical benefit in people.

The central finding is that nutrient stress can drive ACSS1-dependent metabolic rewiring, mitochondrial damage and impaired bone formation through a pathway involving ME2 acetylation.

Subject of Research: ACSS1-mediated metabolic stress and impaired bone formation in mouse models

Article Title: Nutrient stress-driven ACSS1 controls metabolic flexibility and bone formation

Article References: Gao, L., Yuan, Z., Huang, T., Li, P., Zhong, Y., Gao, J., Luo, Y., Li, B., Pan, H., Ye, K., & Guan, M. (2026). Nutrient stress-driven ACSS1 controls metabolic flexibility and bone formation. Nature Communications. https://doi.org/10.1038/s41467-026-77684-w

Image Credits: AI Generated

DOI: 10.1038/s41467-026-77684-w

Keywords: ACSS1, nutrient stress, bone formation, bone marrow stem cells, mitochondrial dysfunction, osteogenesis, protein acetylation, ME2, type 2 diabetes, osteoporosis, Nutrient, stress-driven

Sarcopenia is one of the most consequential and least well understood consequences of aging. As muscle fibers shrink and mitochondria, the cell’s energy factories, falter, older adults lose the strength to climb stairs, carry groceries or recover from illness, and their risk of falls, frailty and metabolic disease climbs sharply. While adult lifestyle factors such as inactivity and poor diet are known contributors, the question of whether nutrition in the earliest window of life can set the trajectory of muscle aging has remained largely unexplored. The new findings suggest it can.

The team used mouse models in which pups were overfed during the neonatal period, a developmental stage in rodents that corresponds broadly to infancy in humans. Litter sizes were manipulated so that some pups received more milk than others during suckling, creating a controlled form of early overnutrition. The animals were then followed into old age. Compared with normally fed controls, the overfed mice had shorter lifespans, worse late-life muscle atrophy and clear metabolic dysfunction, including disturbances in glucose handling. Crucially, the effect appeared in both sexes, indicating that the developmental programming was not a sex-specific quirk.

The mechanistic heart of the study lies in the gut. Neonatal overfeeding, the researchers found, disrupts the development of goblet cells, the specialized epithelial cells that secrete the protective mucus layer lining the intestine. This layer is far more than passive lubrication. It forms a physical barrier that separates the dense microbial community of the gut from the underlying immune tissue, and its composition, particularly its supply of mucin glycans, determines which microbes can thrive there. When goblet cell development goes awry, the mucus barrier remains defective for life, and the consequences ripple outward across the lifespan.

One microbe proved especially sensitive to this altered environment: Akkermansia muciniphila, a well-known mucus-dwelling bacterium that has attracted intense interest for its associations with metabolic health. In the overfed mice, the persistent mucus barrier defects led to reduced colonization by A. muciniphila as the animals aged. The loss was not merely a correlate. When the researchers performed fecal microbiota transplantation, transferring gut microbes from overfed, sarcopenic mice into recipient animals, the sarcopenic phenotype came along with the microbes, directly implicating gut dysbiosis in the propagation of the muscle-wasting disease.

Why would the disappearance of a single gut bacterium weaken skeletal muscle? The answer appears to run through a short-chain fatty acid called acetate. A. muciniphila is a producer of acetate, a metabolite that circulates systemically and signals to host tissues through receptors including GPR43, also known as FFAR2, a G-protein-coupled receptor expressed in tissues including muscle and immune cells. In the mice lacking A. muciniphila, acetate production dropped, GPR43 signaling was suppressed, and muscle mitochondria suffered. Mitochondrial function in the aged muscle was impaired, meaning the fibers could not efficiently generate the energy required to maintain their mass and contractile performance. The result was aggravated sarcopenia.

The most striking part of the study is that the damage proved reversible, at least in aged mice. When the researchers reconstituted A. muciniphila, either by giving the bacterium directly or by supplementing acetate, mitochondrial homeostasis in the muscle was restored and physical performance improved. This rescue experiment closes the causal loop: it shows not only that the loss of the microbe accompanies muscle decline but that restoring the microbe or its key metabolite can meaningfully improve muscle function late in life. It also identifies acetate signaling through GPR43 as a concrete molecular target linking gut ecology to mitochondrial health in skeletal muscle.

The broader significance of the work is its reframing of sarcopenia as a disease with developmental origins. The concept of the developmental origins of health and disease holds that nutritional and environmental exposures during critical windows of early development can permanently shape physiology and disease risk decades later. Most research in this area has focused on cardiovascular and metabolic outcomes. This study extends the paradigm to the musculoskeletal system and supplies a mechanistic pathway: early overnutrition reprograms gut mucosal development, which reshapes the microbiota, which in turn alters metabolite availability and mitochondrial function in muscle across the lifespan. The gut-muscle axis, as the authors describe it, becomes a conduit through which an infantile dietary excess is converted into an aged, weakened body.

There are important caveats. The findings come from mice, and the neonatal overfeeding model, while well established, involves litter-size manipulation that does not map perfectly onto human infant feeding practices. Human infancy involves a different developmental timeline, different milk composition and a far more variable nutritional environment. Whether overfeeding during human infancy accelerates muscle aging through an analogous goblet cell and A. muciniphila pathway remains an open question that will require long-term human cohort studies. The authors themselves frame the work as revealing a developmental origin of age-related sarcopenia and defining a gut-muscle axis, rather than as a demonstration of a clinical intervention.

Even so, the preventive implications are considerable. If early-life overnutrition leaves a lifelong imprint on the gut barrier and microbiota, then optimizing infant nutrition could be a form of preventive medicine for healthy aging, protecting not only against childhood obesity and adult metabolic disease but against the frailty of old age. The rescue experiments point to a second, complementary possibility: that A. muciniphila or acetate-based interventions might one day help preserve muscle function in people already aging with an unfavorable microbial legacy. As populations worldwide grow older and sarcopenia imposes mounting costs on health systems, the idea that the seeds of late-life muscle decline are planted in the first weeks of life, and that they may be weeded out through the gut, is a finding likely to reshape how researchers think about aging, nutrition and the microbes that live along for the ride.

Subject of Research: How neonatal overfeeding programs lifelong gut mucosa and microbiota changes that accelerate age-related sarcopenia in mice

Article Title: Neonatal overfeeding accelerates age-related sarcopenia and metabolic disorders through lifelong gut mucosa and microbiota programming in mice

Article References: Song, Y., Xu, J., Zhao, J., Yang, R., Ma, Y., Hou, Y.-M., Cao, Y., Li, J., Yu, S., Liang, X., Zhang, Y., Wang, K., An, L., Liu, Y., Meng, Z.-X., Fan, J.-G., & Xie, C. (2026). Neonatal overfeeding accelerates age-related sarcopenia and metabolic disorders through lifelong gut mucosa and microbiota programming in mice. Nature Communications. https://doi.org/10.1038/s41467-026-78216-2

Image Credits: AI Generated

DOI: 10.1038/s41467-026-78216-2

Keywords: sarcopenia, neonatal overfeeding, gut microbiota, Akkermansia muciniphila, goblet cells, mucus barrier, acetate, GPR43, mitochondria, muscle aging, developmental origins, metabolic disorders

Volatile fatty acids are short-chain organic acids, chiefly acetate, propionate, and butyrate, that microbes generate when they break down organic material in the absence of oxygen. Far from being mere waste products, these acids are prized building blocks for the bio-based economy. They can serve as carbon sources for bioplastics, precursors for biofuels, and raw materials for a range of chemicals that are currently derived from petroleum. The appeal of producing them from food waste is obvious: the feedstock is cheap, abundant, and otherwise a disposal liability. Yet the fermentation process is notoriously sensitive to conditions, and yields can vary dramatically depending on what goes into the tank.

The research team, led by Xingye Cheng and corresponding author Maimaiti Simayi, set out to quantify that variability. They selected six substrates representative of typical fruit and vegetable waste: potato, Chinese cabbage, radish, apple, tomato, and watermelon rind. Each was fermented anaerobically at two temperatures, 35 degrees Celsius and 45 degrees Celsius, spanning the range between conventional mesophilic operation and a moderately thermophilic regime. By holding other variables constant and varying only temperature and substrate, the researchers could isolate the influence of each factor on both the quantity and the composition of the acids produced.

The results revealed a striking hierarchy among the substrates. Apple and tomato emerged as the champion acid producers, achieving VFA concentrations of 6,858.96 plus or minus 197.9 milligrams of VFA per gram of volatile solids and 5,740.0 plus or minus 159.33 milligrams of VFA per gram of volatile solids, respectively. Volatile solids, measured as the fraction of total solids that burns off at high temperature, serve as a proxy for the biodegradable organic content of a substrate. The researchers attribute the superior performance of apple and tomato to two characteristics: high organic purity, with a volatile solids to total solids ratio exceeding 0.96, and an abundance of readily soluble sugars that acidogenic bacteria can ferment with ease.

This finding carries a practical message for waste managers and biorefinery operators. Not all fruit and vegetable waste is created equal, and the organic composition of each substrate substantially shaped its acidogenic performance in the study. Substrates laden with soluble carbohydrates essentially hand the fermenting microbes their food in a pre-digested form, allowing rapid acid accumulation. By contrast, wastes rich in structural compounds or with a lower proportion of fermentable organics deliver more modest yields. Sorting and blending waste streams by their biochemical profile, rather than treating all produce refuse as an undifferentiated mass, could therefore meaningfully improve the economics of VFA production facilities.

Temperature proved to be the other decisive lever. At 45 degrees Celsius, most of the tested substrates yielded higher total VFA concentrations than their counterparts fermented at 35 degrees Celsius, with an average increase of 25.3 percent. The mechanism is rooted in microbial kinetics: warmer conditions accelerate enzymatic activity and metabolic throughput in the acidogenic community, allowing bacteria to hydrolyze and ferment organic matter faster. Elevated temperature also tends to suppress certain competing populations, including methanogens that would otherwise consume the acids and convert them into biogas, thereby preserving the desired products in the liquid phase.

Perhaps the most consequential effect of the higher temperature was on the composition of the acid mixture. At 45 degrees Celsius, fermentation shifted markedly toward acetate and butyrate while reducing the proportion of propionate. This compositional shift matters enormously downstream. Acetate is the preferred substrate for producing polyhydroxyalkanoates, biodegradable plastics synthesized by certain bacteria, and it is also a key feedstock for chain-elongation processes that generate medium-chain fatty acids. Butyrate has its own portfolio of applications, from animal feed additives to pharmaceutical intermediates. Propionate, while useful, is often less desirable in high proportions because it can inhibit downstream microbial processes and is more difficult to upgrade. A fermentation recipe that naturally favors acetate and butyrate therefore simplifies purification and enhances the value of the product stream.

The study also documented distinct fermentation behaviors among the substrates over time. Apple and tomato maintained a stable, low pH throughout the fermentation period, a condition that generally supports sustained acid production and suppresses methanogenic activity. Watermelon rind and Chinese cabbage, in contrast, exhibited pH rebound during the later stages of fermentation, meaning the acidity that built up early on partially neutralized as the process progressed. pH rebound can signal the depletion of readily fermentable sugars or the buffering capacity of the substrate, and it may allow acid-consuming microbes to regain a foothold. For operators, monitoring pH trajectories could serve as an early warning that a particular batch of waste is exhausting its fermentable potential or drifting toward less productive metabolic states.

Taken together, these findings provide a theoretical basis for optimizing fermentation parameters and guiding the efficient utilization of fruit and vegetable waste. The practical implications extend to the design of two-stage anaerobic digestion systems, in which the first stage deliberately produces VFAs that can either be harvested as products or fed onward to methane-producing microbes. Choosing thermophilic operation for the acidogenic stage, and tailoring feedstock mixtures toward sugar-rich substrates such as apple and tomato waste, could boost both the yield and the quality of the acid product. Conversely, substrates with lower acidogenic performance might be blended with sugar-rich materials to balance the feed, or routed to other valorization pathways where their composition is better suited.

The broader context makes this work timely. Food waste accounts for a substantial share of municipal solid waste in many countries, and its decomposition in landfills is a recognized source of greenhouse gas emissions. Converting that waste into volatile fatty acids offers a double dividend: it diverts organic matter from disposal while displacing fossil-derived chemicals with bio-based alternatives. The Xinjiang study adds a crucial piece of engineering knowledge to this emerging field, demonstrating with controlled comparisons that the path from kitchen scraps to chemical feedstock runs through careful attention to temperature and substrate selection. As biorefineries seeking to commercialize waste-derived VFAs move from laboratory to pilot scale, the lesson is clear: the microbes will do the heavy lifting, but only if operators feed them the right waste at the right temperature.

Subject of Research: Effects of temperature and substrate type on volatile fatty acid production during anaerobic fermentation of fruit and vegetable waste

Article Title: Effects of Temperature and Substrate Species on VFA Production Characteristics of Anaerobic Fermentation of Fruit and Vegetable Waste

Article References: Cheng, X., Liu, L., Aikebaier, G., Simayi, M., & Aihemaiti, A. (2026). Effects of Temperature and Substrate Species on VFA Production Characteristics of Anaerobic Fermentation of Fruit and Vegetable Waste. Waste and Biomass Valorization. https://doi.org/10.1007/s12649-026-03783-w

Image Credits: AI Generated

DOI: 10.1007/s12649-026-03783-w

Keywords: anaerobic fermentation, volatile fatty acids, fruit and vegetable waste, temperature, substrate composition, acidogenic performance, acetate, butyrate, propionate, waste valorization, biorefinery, food waste

The research, led by Khurram Tahir with Americo G. Duarte, Inês A.C. Pereira, and Felipe Conzuelo, addressed a stubborn bottleneck that has long limited microbial electrosynthesis, or MES. In conventional MES reactors, electroactive microorganisms sit on a cathode submerged in liquid medium and reduce dissolved carbon dioxide into volatile fatty acids. The trouble is that carbon dioxide dissolves poorly in water, so microbes at a submerged electrode are often starved of carbon no matter how much gas is bubbled through the broth. The team attacked this problem with a gas-diffusion electrode, a porous, PTFE-treated carbon structure that creates a three-phase interface where gas, liquid, and microbial biofilm meet. Carbon dioxide diffuses only a short distance from the gas phase to the hungry biofilm, bypassing the slow dissolve-and-drift route through bulk liquid.

On the other side of the reactor, the researchers swapped out the usual abiotic anode, where water is oxidized to oxygen at a high energetic cost, for a biological one. A graphite felt bioanode was fed with glycerol at 65 millimolar, and the microbial community there harvested electrons from the oxidation of this reduced compound. Because glycerol oxidation is thermodynamically more favorable than water splitting, this arrangement has the potential to lower the overall energy demand of the full cell, while simultaneously converting a low-value biodiesel byproduct into useful chemicals. The two chambers, each holding 100 milliliters, were separated by a Nafion 117 proton-exchange membrane, and the biocathode was held at a controlled potential of minus 0.800 volts versus an Ag/AgCl reference electrode.

The central experiment compared two cathodic carbon-feeding strategies running in parallel reactors. One biocathode received a continuous stream of gaseous carbon dioxide, supplied as an 80:20 mixture with nitrogen at 1.0 milliliter per minute through the gas-diffusion electrode. The other received a single batch dose of 42 millimolar sodium bicarbonate at the start of each run. Both systems were operated through three sequential 96-hour batch cycles, with the electrolyte fully replaced between cycles, allowing the team to track how performance evolved as the biofilms matured. Inocula came from mixed anaerobic sludge collected at the Rio Tranção near Lisbon, enriched separately for six weeks on bicarbonate or glycerol before being introduced into their respective chambers.

The results favored the gas-fed configuration across every measure of cathodic performance. In the first cycle, the carbon dioxide-fed system averaged a cathodic current density of minus 927 milliamperes per square meter, compared with minus 736 for the bicarbonate-fed reactor. By the third cycle, the gap had widened dramatically: the gas-fed system reached minus 1,703 milliamperes per square meter, an 84 percent increase over its starting point, while the bicarbonate system climbed 46 percent to minus 1,075. The estimated charge transferred through the carbon dioxide-fed cathode rose from 288 to 530 coulombs over the same span. Current density peaked at 48 hours in the final cycle, precisely when acetate production in that chamber hit its maximum, a telling coincidence that ties electron flow to product formation.

Acetate was the star product at the biocathode under both conditions, but the gas-fed system outproduced its rival consistently. It reached a maximum acetate concentration of 98 plus or minus 4 millimolar, equivalent to 5.89 grams per liter, in both the first and third cycles, translating to an apparent productivity of 2.94 grams per liter per day. The bicarbonate-fed system peaked at 79 plus or minus 9 millimolar, or 4.74 grams per liter, with a best productivity of 2.28 grams per liter per day. When benchmarked against earlier studies, the carbon dioxide-fed configuration sits comfortably within the reported range of acetate titers for gaseous CO2 systems, which span roughly 1.3 to 7.8 grams per liter, while its current density of minus 1.703 amperes per square meter is comparable to the best carbon-felt systems operating in potentiostatic mode.

The bioanode told its own chemical story. During the first cycle, acetate dominated the volatile fatty acid profile, reaching 84 plus or minus 9 millimolar in the carbon dioxide-fed system and 74 plus or minus 4 in the bicarbonate system. But as the cycles progressed, the product spectrum shifted, and by the third cycle propionate had overtaken acetate as the major product, peaking at 58 plus or minus 10 millimolar in the carbon dioxide-fed reactor. This acetate-to-propionate transition is consistent with known glycerol fermentation routes, including the acrylate and methylmalonyl-CoA pathways, whose activity depends on the redox balance of the enriched community. Butyrate remained negligible throughout, and the researchers caution that residual glycerol was not quantified, so glycerol conversion and anodic carbon recovery could not be calculated.

Electrochemical fingerprints and genetic sequences reinforced the picture. Cyclic voltammetry at the end of the third cycle showed that the carbon dioxide-fed biocathode delivered a maximum cathodic current response roughly 1.5 times higher than the bicarbonate-fed one, minus 15.1 milliamperes versus minus 9.9 at a scan rate of 100 millivolts per second. Sequencing of the 16S rRNA gene revealed strikingly different endpoint communities. The bioanodes were dominated by Firmicutes, accounting for around 60 percent of reads, including the genera Clostridium sensu stricto, Lachnoclostridium, and Proteiniphilum, taxa frequently associated with organic acid production and extracellular electron transfer. The biocathodes instead hosted Proteobacteria, Firmicutes, and Bacteroidota, with the gas-fed cathode notably enriched in Chloroflexi at 16 percent relative abundance, compared with barely 1 percent under bicarbonate feeding, along with elevated Anaerolineae and Bacteroidia.

The authors are careful to frame these findings as an operational comparison rather than a mechanistic proof. The two feeding modes were not matched in cumulative carbon loading or flux, so the performance gap cannot be isolated as a pure gas-diffusion mass-transfer effect. The cathodic chambers contained multiple carbon pools, including citrate from ferric citrate in the medium, yeast extract, and biomass-associated carbon, and no carbon-13 isotope tracing was performed to attribute the acetate to a single source. Each feeding condition was represented by a single reactor, so the sequential cycles serve as analytical rather than biological replicates, and full-cell voltage, glycerol consumption, coulombic efficiency, and energy demand were not monitored. Current densities also remain at least two orders of magnitude below those of conventional carbon dioxide electrolysis, underscoring how far MES still has to travel toward industrial relevance.

Even with those caveats, the study sketches a compelling blueprint for a new class of carbon-recycling reactors. Pairing a gas-diffusion biocathode that drinks gaseous carbon dioxide with a glycerol-fed bioanode that turns a waste stream into both electrons and volatile fatty acids is an elegant piece of integrated engineering, one that attacks carbon supply, anodic overpotential, and waste valorization in a single design. The researchers point toward the next hurdles with unusual candor: gas-diffusion electrodes are notoriously vulnerable to pore flooding, salt accumulation, and loss of hydrophobicity over long runs, and sustained productivity may demand continuous product recovery to prevent inhibition. Future work with isotope tracing, matched carbon loading, independent reactor replicates, and full energy accounting will determine whether this dual-biocatalyzed platform can graduate from a 100-milliliter laboratory curiosity to a genuine technology for turning emissions and biodiesel waste into chemical feedstocks.

Subject of Research: Comparative evaluation of carbon dioxide feeding strategies in dual-biocatalyzed microbial electrosynthesis with a glycerol-fed bioanode

Article Title: Comparative evaluation of CO₂ feeding strategies in a dual-biocatalyzed microbial electrosynthesis system with a glycerol-fed bioanode

Article References: Tahir, K., Duarte, A. G., Pereira, I. A., & Conzuelo, F. (2026). Comparative evaluation of CO₂ feeding strategies in a dual-biocatalyzed microbial electrosynthesis system with a glycerol-fed bioanode. Results in Engineering, 32, Article 113341. https://doi.org/10.1016/j.rineng.2026.113341

Image Credits: AI Generated

DOI: 10.1016/j.rineng.2026.113341

Keywords: microbial electrosynthesis, carbon dioxide, gas-diffusion electrode, glycerol, acetate, bioanode, biocathode, volatile fatty acids, propionate, bioelectrochemistry, microbiome, biodiesel byproduct

The team set out to address a methodological blind spot that has plagued the field for years. Many studies examining the impact of fermented foods on gut microbiota have compared a fermented product against a neutral control, such as water or a standard chow supplement, without accounting for the unfermented substrate from which the product was made. That omission makes it impossible to disentangle the effects of the live cultures, organic acids and metabolites generated during fermentation from the effects of the plant or beverage base itself. To close that gap, the researchers assembled a panel of four popular fermented products: kimchi, sauerkraut, water kefir and kombucha, and paired each one with its respective unfermented control, raw cabbage in the case of the vegetable ferments and unfermented sweetened tea or sugar water for the beverages.

Using murine models, the researchers fed the animals the fermented foods and their unfermented counterparts and then profiled the gut microbiota and the microbial metabolites produced downstream. The experimental design allowed a direct, controlled comparison: if fermentation were the key variable, each fermented item should have produced a distinct microbiota response relative to its unfermented twin. Instead, the results told a more nuanced story. The food matrices themselves, meaning the structural and biochemical composition of the cabbage, tea or sugar solutions, emerged as the primary determinant of how the gut microbial community responded.

Notably, the four products did not behave identically. Kimchi stood out as the clear exception to the matrix-only rule. When the researchers compared kimchi-fed mice with mice receiving unfermented cabbage, they found that the fermented version differentially modulated gut microbiota structure and altered acetate production, a short-chain fatty acid with well-documented roles in gut health, immune signaling and energy metabolism. In other words, for kimchi, fermentation genuinely added something beyond the raw cabbage, changing both which microbes thrived and what those microbes produced.

The fermented beverages told a different story. Water kefir and kombucha, two of the fastest-growing fermented drinks in the global wellness market, did not differ significantly from their unfermented controls in shaping the murine gut microbiota profile or metabolite output. Mice receiving the drinks showed microbiota responses that were essentially indistinguishable from those receiving the corresponding unfermented sugar solutions. For consumers who reach for kombucha specifically for its probiotic promise, the finding does not mean the drinks are without value, but it does suggest that in this mouse model, the fermentation process did not leave a measurable imprint on gut microbial composition beyond what the beverage base itself delivered.

Technically, the study’s strength lies in its paired design and its dual readout. By measuring both microbiota composition, the identity and relative abundance of gut bacterial taxa, and microbial metabolite production, the functional output of the community, the researchers captured two complementary dimensions of gut activity. Microbiota composition can shift without altering function, and metabolite profiles can change even when the taxonomic landscape appears stable. The finding that kimchi influenced both structure and acetate production, while the fermented beverages influenced neither relative to their controls, gives the result a robustness that single-measure studies often lack.

The implications extend well beyond the laboratory. Fermented foods are increasingly promoted as a natural route to delivering beneficial microbes and their metabolites to consumers, and the field has been moving toward using them as tools to deliberately modulate host health. This study provides what the authors describe as an important first step for future research into how fermented foods modulate mammalian gut microbiota composition and function. It also issues a caution: any future trial that fails to include the unfermented substrate as a control risks misattributing matrix effects to fermentation. The food-first framing may prove especially relevant for vegetable ferments, where the fibrous plant matrix, its native phytochemicals and the microbial succession during fermentation appear to interact in ways that sugary beverage matrices do not replicate.

The work also carries a message for the booming commercial fermented beverage sector. Water kefir and kombucha are often marketed on the basis of their live cultures, and laboratory analyses do confirm that these drinks contain viable microorganisms. But delivering microbes in a glass is not the same as changing the ecosystem downstream. Survival through gastric acid, bile salts and competition with resident gut bacteria is a gauntlet that many food-derived strains fail, and the new data suggest that, at least in mice, the contribution of the beverage ferments to gut community structure was negligible once the matrix effect was accounted for. Whether human responses differ remains an open question that the authors’ framework is well positioned to test.

Mouse models, of course, come with caveats. Rodent microbiota differ from human communities in taxonomy and in their response to dietary interventions, and the doses and durations used in animal studies rarely map neatly onto human consumption patterns. The authors are careful to frame the study as a foundational methodological contribution rather than a verdict on any particular product. What it establishes is a rigorous template: matched substrate controls, paired fermented and unfermented treatments, and combined compositional and metabolomic readouts. Applying that template to human cohorts, and to additional fermented foods such as yogurt, kefir, tempeh and sourdough, is the logical next step.

For now, the study delivers a memorable and marketable takeaway that cuts through the hype surrounding fermented foods. The gut does not simply respond to the label on the jar; it responds to the whole food, and fermentation earns its reputation only when it demonstrably changes what the matrix alone would do. Kimchi, in this mouse model, passed that test. The trendy fermented beverages, at least against their own unfermented baselines, did not. As the science of the microbiome-gut axis matures, studies like this one are helping to separate the genuine biology of fermentation from the halo effect of the foods it inhabits, and that distinction may ultimately determine which fermented products earn a place in evidence-based dietary guidance.

Subject of Research: Effects of fermented foods and their unfermented substrate controls on gut microbiota composition and microbial metabolite production in mice

Article Title: Fermented food matrix influences gut microbiota responses in mice

Article References: Balasubramanian, R., Bietto, F., de Paula Dias Moreira, L., Giblin, L., Nilaweera, K. N., Cotter, P. D., & Cryan, J. F. (2026). Fermented food matrix influences gut microbiota responses in mice. npj Science of Food. https://doi.org/10.1038/s41538-026-01149-z

Image Credits: AI Generated

DOI: 10.1038/s41538-026-01149-z

Keywords: fermented foods, gut microbiota, kimchi, sauerkraut, water kefir, kombucha, food matrix, short-chain fatty acids, acetate, mouse model, microbiome, fermentation

The research team began by characterizing what aging actually does to the body before any infection takes place. They compared young C57BL/6 mice, aged eight to twelve weeks, with old mice aged twenty-four months. Microscopic examination of lung tissue revealed disrupted cytoskeletal architecture in the old animals, a sign of structural deterioration. Blood analysis showed pronounced systemic inflammation, with significantly elevated levels of interferons, the pro-inflammatory cytokines IL-6 and IL-1β, and chemokines such as IL-8, MCP-1, and CXCL-1. The anti-inflammatory cytokine IL-10, itself a factor secreted by senescent cells, was also elevated. Transcriptomic profiling of lung tissue confirmed the picture, revealing enrichment of inflammation-related pathways including phagosome activity, antigen presentation, and cytokine-cytokine receptor interactions, all pointing to heightened immune activation in the aged lung even in the absence of any pathogen.

The gut told a parallel story. Shotgun metagenomic sequencing of fecal samples showed marked age-associated shifts in microbial composition, with an increased abundance of the genus Clostridium and a significant depletion of Faecalibaculum in the old mice. An analysis of similarities confirmed that the microbial communities of old and young mice differed significantly at the genus level. Taken together, these baseline findings established a coordinated profile of aging: systemic cytokine elevation, inflammatory transcriptional changes in the lung, and gut dysbiosis, providing the foundation for asking how these changes shape the response to viral infection.

When the researchers infected both age groups with a sublethal dose of influenza A virus, distinct age-dependent patterns emerged. Young mice mounted an early, transient response, showing higher clinical scores during the first days of infection but recovering fully by the end of the observation period. Old mice followed a different trajectory: their clinical deterioration appeared later, from day eight onward, and their body weight never fully returned to baseline by day twenty-one. Critically, the bronchoalveolar lavage fluid of old mice contained higher viral loads on day eight, along with elevated levels of IL-6, IP-10, and IFN-γ. In other words, the aged animals cleared the virus more slowly while simultaneously producing more inflammatory signaling molecules.

Transcriptomic analysis of lung tissue mirrored this delayed but exaggerated response. On day four post-infection, infected old mice showed relatively subdued inflammatory gene expression compared with infected young mice, including significantly decreased expression of several type I and type III interferons such as Ifnl2, Ifna4, and Ifnl3. By day eight, however, the old mice displayed a significant surge in inflammation-related genes, with the notable exception of the interferons, alongside enrichment of pattern recognition receptor pathways such as Toll-like receptor cascades. This pattern suggests that aging disrupts the coordination between early antiviral immunity and the later resolution of inflammation, allowing both the virus and the inflammatory response to persist longer.

The most novel part of the study concerned what was happening in the gut during infection. Shotgun metagenomics of samples taken at baseline, day four, and day twenty-one post-infection revealed that influenza infection transiently reshaped the microbiome in both age groups, with decreases in Bacillota and increases in Verrucomicrobiota and Pseudomonadota during the acute phase. Akkermansia increased in both groups, most prominently in old mice, while species-level analysis showed that the two most abundant species, Faecalibaculum rodentium and Akkermansia muciniphila, were significantly decreased in old mice even before infection and remained lower throughout. Linear discriminant analysis highlighted strong effect sizes for these beneficial species in young mice, and for Escherichia coli and Parabacteroides goldsteinii in old mice during the acute phase.

More revealing than the taxonomic shifts were the changes in metabolic potential. Genes annotated to the CAZy database showed that enzymes involved in glucose fermentation were transiently upregulated in both age groups during acute infection, with the effect particularly pronounced in old mice, consistent with the central role of carbohydrate fermentation in short-chain fatty acid production. However, KEGG-based functional annotation indicated a potential decline in pyruvate production via the Entner-Doudoroff pathway and, crucially, reduced acetate generation through pyruvate dehydrogenase (quinone) in the old animals. Because acetate is a major microbiota-derived metabolite with established immunomodulatory and antiviral properties, this age-related decline in acetate-associated metabolism suggested a concrete mechanistic link between gut dysfunction and impaired antiviral defense.

To test that link directly, the team turned to a human cell model. They induced senescence in primary human lung fibroblasts (IMR-90 cells) using doxorubicin, confirming the senescent state through upregulation of p21, downregulation of Lamin B1, and elevated senescence-associated secretory phenotype markers. Flow cytometry revealed that senescent cells significantly overexpressed FFAR2 and FFAR3, the G-protein-coupled receptors that mediate short-chain fatty acid signaling. Consistent with the group’s previous work, senescent fibroblasts proved markedly more permissive to influenza A virus than quiescent controls, replicating the virus to much higher levels. But when the cells were pre-treated with 260 micromolar acetate for twenty-four hours before infection, viral replication dropped significantly, and inflammatory cytokine output was dampened, all without compromising cell viability. Acetate, in effect, restored a measure of antiviral defense to the aged cells.

The mechanism appears to be both immunological and epigenetic. RNA sequencing showed that influenza-infected senescent cells upregulate numerous inflammation and pathogen recognition pathways, including NF-κB and NOD-like receptor signaling, whereas these pathways remained largely unchanged when acetate was present. Ingenuity Pathway Analysis confirmed that pathogen-induced cytokine storm signaling was strongly elevated in infected senescent cells but attenuated by acetate treatment, while pathways linked to cellular senescence itself were unaffected. Acetate also enhanced pathways related to oxidative phosphorylation and reactive oxygen species production, suggesting it pushes cells toward a metabolic state less permissive to viral replication. The enzyme ACSS2, which activates acetate for histone modification, was upregulated in senescent fibroblasts, and histone extracts revealed that influenza infection decreased H3 acetylation in senescent cells, a reduction that acetate supplementation restored. Histone deacetylase activity, reduced at baseline in senescent cells, was likewise normalized by acetate. This coordinated epigenetic remodeling likely underlies the broad transcriptional changes that suppress both viral replication and cytokine overproduction.

The authors are careful to note the limits of the current work. Direct quantification of short-chain fatty acids, metabolomic profiling of primary old human lung tissue, and validation in clinical cohorts will be needed to establish a firm causal relationship between microbiota-derived metabolites and antiviral resilience in aging humans, and to determine whether circulating acetate levels correlate with influenza severity in older patients. Even so, the study delivers a compelling translational framework: age-associated gut dysbiosis reduces the microbial capacity to produce acetate, and this decline in metabolite availability directly compromises antiviral responses in senescent lung cells through FFAR2/FFAR3 signaling and histone acetylation. Because individuals over sixty experience substantially higher morbidity, mortality, and prolonged hospitalization from influenza, the identification of a modifiable, microbiota-derived mediator opens a concrete therapeutic avenue. Host-directed interventions that boost acetate availability, whether through diet, probiotics, or targeted metabolite supplementation, could one day help restore antiviral resilience in the aging lung, complementing vaccines rather than replacing them.

Subject of Research: Age-associated gut microbiota dysbiosis, short-chain fatty acid metabolism, and impaired antiviral defense during influenza infection

Article Title: Age‐Associated Gut Microbiota Dysbiosis Impairs Antiviral Defense During Influenza Virus Infection and Identifies Acetate as a Protective Mediator in Senescent Human Lung Cells

Article References: Wernike, C., Häder, A., Reisser, Y., Garakani, K., Hornung, F., Le Saux, C. J., & Deinhardt‐Emmer, S. (2026). Age‐Associated Gut Microbiota Dysbiosis Impairs Antiviral Defense During Influenza Virus Infection and Identifies Acetate as a Protective Mediator in Senescent Human Lung Cells. Aging Cell, 25(10), Article e70750. https://doi.org/10.1111/acel.70750

Image Credits: AI Generated

DOI: 10.1111/acel.70750

Keywords: gut microbiota, aging, influenza A virus, acetate, short-chain fatty acids, gut-lung axis, cellular senescence, FFAR2, histone acetylation, antiviral immunity, dysbiosis, lung fibroblasts

The starting point for the investigation was a careful characterization of what actually goes wrong in diarrheic calves. Compared with healthy animals, calves suffering from neonatal diarrhea showed pronounced gut microbial dysbiosis, meaning the composition of their intestinal bacterial communities had shifted away from a balanced state, together with measurable metabolic perturbation and clear signs of inflammatory activation. These observations established the pathological backdrop against which any candidate intervention would need to be evaluated, and they highlighted the possibility that restoring a healthy microbial community might restore a healthy gut.

To test that possibility directly, the researchers turned to fecal microbiota transplantation, or FMT, a technique that transfers the entire gut microbial community from healthy donor animals into sick recipients. When fecal material from healthy calves was transplanted into diarrheic calves, the treatment alleviated diarrhea. Crucially, the recovery was accompanied by enrichment of B. pseudocatenulatum in the recipients’ intestines and by an increase in fecal acetate, one of the major short-chain fatty acids produced by bacterial fermentation in the gut. This correlation gave the team two concrete leads: a specific bacterial species and a specific bacterial metabolite that moved in the same direction as clinical improvement.

The next step was to determine whether the bacterium itself could generate the acetate signal. In laboratory cultures, live B. pseudocatenulatum increased acetate production, confirming that this species is a genuine acetate producer rather than a passive correlate of health. This matters because it establishes a plausible causal route from bacterium to metabolite to host physiology, rather than a mere association, and it focused the team’s attention on acetate as the likely functional mediator of the probiotic effect.

To dissect that mechanism under controlled conditions, the investigators used complementary murine inflammatory models, in which mice were subjected to inflammatory challenges that mimic the intestinal damage seen in diarrheic calves. Treatment with live B. pseudocatenulatum or with acetate itself alleviated intestinal injury and the associated inflammatory phenotypes in these animals. By contrast, the protective effect was attenuated in mice given heat-killed B. pseudocatenulatum, a result with important mechanistic implications: a dead bacterium cannot ferment substrates into metabolites, so the loss of protection when the organism is killed points squarely to an activity of living bacteria, most plausibly their metabolic output, as the source of the benefit rather than a structural component of the bacterial cell.

Perhaps the most technically interesting part of the study concerns the immune pathway that the bacterium and its metabolite engage. The team found that the protective effects were accompanied by attenuation of pathogen-induced Th17/IL-17A-related responses. The Th17 lineage is a subset of CD4-positive T helper cells defined in large part by their production of the cytokine interleukin-17A, a potent inflammatory messenger that recruits neutrophils and drives antimicrobial defense but also fuels tissue damage when overactivated. Importantly, the authors emphasize that the effect was not a broad suppression of basal Th17 activation; the bacterium and acetate selectively dampened the exaggerated, pathogen-driven arm of this response while leaving ordinary Th17 activity largely intact. That selectivity is a desirable property for any anti-inflammatory therapy, because wholesale immune suppression would leave young animals vulnerable to infection.

The team then probed the receptor side of the acetate signal. Acetate can signal to host cells through free fatty acid receptor 2, or FFAR2, a G-protein-coupled receptor expressed on immune and epithelial cells that functions as a sensor for short-chain fatty acids. When the researchers used pharmacological blockade of FFAR2, the protective effect of live B. pseudocatenulatum was attenuated, supporting the involvement of acetate-associated receptor signaling in the probiotic benefit. Complementary experiments reported in the supplementary material of the study also showed that Brodalumab, an antibody that blocks the signaling of IL-17 family cytokines, counteracted the protective effect of acetate in a mouse colitis model driven by Salmonella Typhimurium, further tying the pathway together at the cytokine level.

The murine models tested a range of inflammatory insults beyond a single pathogen, and the results were consistent across them. B. pseudocatenulatum and acetate, supplied as sodium acetate, protected against intestinal injury in mice challenged with Escherichia coli and in models of Salmonella Typhimurium-induced inflammation and DSS-induced colonic inflammation. In the E. coli-challenged mice, the bacterium restored intestinal morphology, promoted acetate production, remodeled gut microbiota composition, and modulated T-cell subsets and inflammatory factors, along with the expression of genes involved in immune responses and metabolism in the intestinal epithelium. Supplementary analyses in calves showed that sodium acetate supplementation influenced serum biochemical indicators, extending the metabolite-level evidence to the target species itself.

Taken together, the study lays out a coherent mechanistic framework: dysbiosis in diarrheic calves depletes protective, acetate-producing taxa such as B. pseudocatenulatum; restoring those taxa, whether by whole-community FMT or by targeted supplementation, replenishes the acetate pool; acetate then acts through FFAR2 to restrain the pathogen-induced surge of the Th17/IL-17A axis, thereby reducing intestinal inflammation and the diarrhea it produces. The authors present this as one component of the bacterium’s protective effect rather than the whole story, a measured framing that reflects the inherent complexity of gut ecosystems and the many metabolites and immune circuits that operate in parallel.

The practical implications are considerable. Neonatal calf diarrhea imposes substantial economic losses on dairy and beef operations worldwide, and current management relies heavily on antibiotics, rehydration therapy, and husbandry measures, approaches that face growing pressure from antimicrobial resistance concerns. A defined probiotic species with an understood mechanism of action, acting through a well-characterized metabolite and receptor pathway, offers a rational and mechanistically grounded alternative or complement to existing treatments. More broadly, the microbiota–metabolite–immune regulatory framework established in this work provides a template that researchers in animal science and human gastroenterology alike can use to dissect how specific commensal organisms and their metabolic products tune inflammatory responses, and it underscores how much therapeutic insight can be extracted from tracing a single bacterial species and its small-molecule signal from the feces of a sick calf all the way to a cytokine axis in the gut wall.

Subject of Research: Acetate-mediated immune modulation by Bifidobacterium pseudocatenulatum in neonatal calf diarrhea

Article Title: Bifidobacterium pseudocatenulatum alleviates neonatal calf diarrhea via acetate-associated attenuation of pathogen-induced Th17/IL-17A inflammatory responses

Article References: Hu, M., Du, W., Li, W., Du, Y., Si, W., Hou, J., Gao, Y., Yang, L., Sun, H., Liu, H., Yu, Z., Guan, L., & Xu, Q. (2026). Bifidobacterium pseudocatenulatum alleviates neonatal calf diarrhea via acetate-associated attenuation of pathogen-induced Th17/IL-17A inflammatory responses. Microbiome. https://doi.org/10.1186/s40168-026-02524-4

Image Credits: AI Generated

DOI: 10.1186/s40168-026-02524-4

Keywords: Bifidobacterium pseudocatenulatum, neonatal calf diarrhea, gut microbiome, acetate, short-chain fatty acids, Th17 cells, IL-17A, FFAR2, intestinal inflammation, fecal microbiota transplantation, probiotics, livestock health

Synthetic consortia represent an emerging frontier in biotechnology, and their appeal lies in the principle of division of labor. Rather than cramming every metabolic function into a single organism, researchers can distribute tasks across specialized members, each optimized for its role. This approach reduces the metabolic burden on any one cell, improves robustness, and, according to the authors, offers a reduced risk of contamination because the engineered partners occupy the ecological niche that invaders would otherwise exploit. Consortia that combine phototrophic and heterotrophic bacteria are especially attractive because the phototrophic partner can harvest light energy and fix atmospheric CO2, effectively converting an abundant greenhouse gas into organic carbon that sustains the rest of the community.

Most previous explorations of such phototrophic–heterotrophic partnerships have relied on sucrose as the transferred carbon source. Sucrose, however, is a relatively large molecule, and its export and import require dedicated transport machinery. Acetate offers a simpler alternative. It is a small two-carbon compound produced naturally as a by-product by many microorganisms, including the model cyanobacterium Synechocystis PCC 6803, the workhorse of cyanobacterial synthetic biology. The catch is that wild-type cyanobacteria secrete only trace amounts of acetate during phototrophic growth—far too little to support a productive industrial partnership.

The Uppsala team solved this problem in earlier work through targeted metabolic engineering. By introducing a phosphoketolase, or PK, an enzyme that reroutes carbon flux through the central carbon metabolism of the cyanobacterium, and by overexpressing phosphotransacetylase, or Pta, the enzyme that channels acetyl-phosphate toward acetate, they created a high-producing strain designated WT_PKPa_RBS_BsPta_Δacs. The acs deletion prevents re-assimilation of secreted acetate, locking the cell into an export phenotype. The resulting organism secretes significant levels of acetate into its growth medium, turning it into a living, sunlight-powered carbon factory.

With the acetate donor in hand, the next challenge was to build reliable consumers. Roussou and Lindblad engineered two different heterotrophs for 1-butanol production: Escherichia coli, the standard bacterium of metabolic engineering, and Pseudomonas taiwanensis, a robust soil-dwelling species increasingly favored for its tolerance of harsh conditions. Both strains were first cultivated on acetate as their sole carbon source, demonstrating that they could grow on the very molecule the engineered cyanobacterium produces. Only after this critical validation were the partners combined.

The researchers then established two distinct synthetic consortia, pairing the acetate-secreting Synechocystis strain individually with each of the butanol-producing heterotrophs. Remarkably, the co-cultures were maintained for 42 days, an extended duration that speaks to the stability of the engineered partnerships. Throughout the experiment, the team successfully monitored growth dynamics, tracking how each member of the community fared over more than a month of continuous co-existence under phototrophic conditions.

The measurements told a coherent story. Acetate concentrations in the consortia were lower than in a corresponding axenic Synechocystis culture, a difference that indicates the heterotrophic partners were actively consuming the carbon being secreted by the cyanobacteria. In other words, the engineered phototroph was not merely dumping acetate into the medium; it was feeding its partners. Crucially, 1-butanol was detected in both co-cultures, confirming that the transferred photosynthetic carbon was being converted into the desired end product by the engineered E. coli and P. taiwanensis strains.

This demonstration is conceptually important because it closes a loop that many in the field have tried to close. Photosynthetic microbes can fix CO2 with sunlight, but they are often inefficient producers of complex chemicals. Heterotrophic microbes are superb synthetic chemists but need organic feedstocks, which typically come from plant biomass or sugar in conventional biorefineries. By coupling the two through acetate, the study shows that a renewable, food-independent supply chain is technically feasible: sunlight and CO2 in, acetate out of one organism, and 1-butanol out of another, all within a single co-culture vessel.

1-Butanol itself is a compelling target. It is a four-carbon alcohol with fuel properties closer to gasoline than ethanol, making it attractive as a drop-in biofuel or blending component, and it also serves as a precursor for paints, coatings, polymers, and solvents. Industrial production currently relies on petrochemical routes or on traditional Clostridium fermentations that require sugar feedstocks and suffer from solvent toxicity to the producing organism. Outsourcing butanol synthesis to heterotrophs fed by a photosynthetic partner could, in principle, decouple production from agricultural inputs while the cyanobacterium simultaneously captures CO2.

The work, funded by the European Union’s Horizon 2020 research and innovation program under the PROMICON project, also carries practical lessons for the broader synthetic ecology community. Maintaining a stable consortium for six weeks shows that carefully matched production and consumption rates can keep the partnership in balance, and the detectable butanol titers in both pairings suggest the acetate channel is robust across different heterotrophic chassis. Challenges remain before such systems approach industrial relevance, including raising acetate secretion rates, improving butanol titers and tolerance, and scaling photobioreactor conditions. Yet the study establishes a clear proof of principle: photosynthetically derived acetate can sustain heterotrophic production of a value-added bulk chemical in a designed microbial community, charting a path toward sunlight-driven biomanufacturing built on cooperation rather than a single overloaded cell.

Subject of Research: Synthetic phototrophic-heterotrophic bacterial consortia engineered to convert photosynthetically derived acetate into 1-butanol

Article Title: Synthetic consortia towards photosynthetically derived acetate for heterotrophic production of 1-butanol

Article References: Roussou, S., & Lindblad, P. (2026). Synthetic consortia towards photosynthetically derived acetate for heterotrophic production of 1-butanol. Applied Microbiology and Biotechnology, 110(1), Article 268. https://doi.org/10.1007/s00253-026-14029-z

Image Credits: AI Generated

DOI: 10.1007/s00253-026-14029-z

Keywords: synthetic consortia, Synechocystis PCC 6803, Escherichia coli, Pseudomonas taiwanensis, acetate, 1-butanol, cyanobacteria, metabolic engineering, synthetic biology, CO2 fixation, biofuels, phototrophic-heterotrophic co-culture